Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-12T13:46:57.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-05T09:26:00.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-26T04:04:17.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-11T18:11:40.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T12:01:43.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T04:26:52.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.